COMMUNIQUÉS West-GlobeNewswire

Evaxion Biotech Announces Pricing of $15 Million Public Offering
01/02/2024
COPENHAGEN, Denmark, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today [...]
Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
01/02/2024
SAN DIEGO, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the approval [...]
Our Place Celebrates 2023 Community Impact Milestones and Looks Ahead to Further Outreach in 2024
01/02/2024
The New York-based nonprofit organization for at risk youth struggling with addiction and substance abuse saw record attendance and community outreach in 2023 NEW YORK, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Our Place (the “ [...]
Parexel Appoints Susan R. Salka to Board of Directors
01/02/2024
Ms. Salka brings more than 30 years of healthcare leadership and staffing expertise, including strong C-suite, financial and ESG expertise to advance the company’s Patients-first focus and growth initiatives DURHAM, N.C [...]
Celularity Announces Net Sales Expectations for First Quarter 2024 and Full Year 2024, Reiterates Advanced Biomaterial Product Commercial and Development Pipeline
01/02/2024
Continuing the substantial growth trajectory that began during 2023, for the first quarter 2024 and the full year 2024, Celularity expects triple-digit percentage increases in combined net sales of its advanced [...]
HeartSciences Appoints New Scientific Advisory Board Member
01/02/2024
Southlake, TX, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company") , an artificial intelligence (AI)-powered medical technology [...]
SPR® Therapeutics Announces $85 Million in Additional Funding to Advance Rapid Commercial Expansion of the SPRINT® PNS System
01/02/2024
CLEVELAND, Feb. 01, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic pain, today announced [...]
Pressure BioSciences Upcoming Investor Call to Discuss Recent Acquisition of Uncle Buds
01/02/2024
Uncle Bud’s 2024 Revenue Expected to Increase 3-Fold to Approximately $5 Million, Fueled by UltraShear Processed Nanoemulsion Product Introductions and Exciting New Market Opportunities SOUTH EASTON, Mass., Feb. 01, [...]
Renowned Actor and Artist Ice-T Works Alongside the International Myeloma Foundation to Raise Awareness of Multiple Myeloma in the African American Community During Black History Month
01/02/2024
STUDIO CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Working alongside the International Myeloma Foundation (IMF), American songwriter, actor, producer, and well-known artist Ice-T is on a mission to help raise [...]
Autonomix Medical, Inc. (NASDAQ: AMIX) to Present at the Virtual Investor New to the Street Event
01/02/2024
Live moderated webcast with members of the Autonomix management team on Wednesday, February 7 th at 10:00 AM ET THE WOODLANDS, TX, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or [...]
Renexxion to Present at the Oppenheimer 34ᵗʰ Annual Healthcare Life Sciences Conference
01/02/2024
ROSCREA, Ireland, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Renexxion Ireland Limited (“Renexxion”), a private biopharmaceutical company committed to delivering innovative drugs to patients with high unmet need in [...]
Teladoc Health to Announce Fourth Quarter 2023 Financial Results
01/02/2024
PURCHASE, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release fourth quarter 2023 results on Tuesday, February 20, [...]
CytoDyn Announces Submission of Clinical Protocol to FDA and Initiation of Pre-Clinical Study in Glioblastoma
01/02/2024
VANCOUVER, Washington, Feb. 01, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple [...]
SS Innovations Demonstrates Groundbreaking Telesurgery Platform at Company’s First Multi-Specialty Robotic Surgical Conference
01/02/2024
Remote coronary artery suturing performed on animal model via SS Innovations’ telesurgery platform SMRSC 2024 welcomed global medical experts and innovators to explore the future of robotic surgery FORT LAUDERDALE, Fla [...]
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
01/02/2024
FARMINGDALE, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading life science company, announced the voting results from its Annual Meeting held on January 31, 2024 [...]
SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device Technology
01/02/2024
DENVER, Feb. 01, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, [...]
Dyadic to Attend BIO CEO & Investor Conference and European Industry Events
01/02/2024
JUPITER, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the [...]
Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research Center
01/02/2024
The licensing agreement refers to the company's dedicated treatment for cocaine addiction which previously indicated a significant decrease in cocaine craving Tel Aviv, Israel / Vancouver, Canada, Feb. 01, 2024 (GLOBE [...]
Mersana Therapeutics to Participate in Guggenheim’s 6th Annual Biotechnology Conference
01/02/2024
CAMBRIDGE, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates ( [...]

Pages